Ceftriaxone-associated nephrolithiasis and gallstone in adults
Open Access
- 1 December 2018
- journal article
- research article
- Published by Taylor & Francis in Drug, Healthcare and Patient Safety
- Vol. ume 10, 103-108
Abstract
Background: Ceftriaxone (CTX) is widely used for the treatment of bacterial infections; however, side effects such as gallstone and nephrolithiasis have been reported in children. There is limited information about urinary tract calculi as CTX side effects in adults. Therefore, the present study was aimed to evaluate the incidence of gallstone and nephrolithiasis following CTX administration. Methods: The present study was conducted in the Vali-e-Asr Hospital. Eighty-four patients with various infectious diseases with different daily treatment (mean ± SD: 4.19±2.54) were included in this study, consisting of 49 females and 35 males. The mean of total doses used in patients was 10.2143 (SD: 5.8585). To detect possible gallstone, gallbladder sludge, and urolithiasis, patients were evaluated by serial ultrasound before and after CTX treatment. Patients with renal and hepatobiliary dysfunction were excluded from the study and did not receive any nephrotoxic drugs during this study. Demographic parameters including age, sex, body mass index, dosage of CTX, as well as the duration of treatment and hospitalization were determined. Statistical significances were determined using Fisher’s exact test and independent t-test. Results: Results from our study showed that the incidence of gallstone and nephrolithiasis were 8.8% and 1.5% following CTX administration, respectively. Surprisingly, we found a significant correlation in terms of age between patients with and without gallstone (P=0.03). Conclusion: Our findings suggest that the patients’ age might play a role in the development of such a complication. This indicates the need for a close monitoring of CTX-treated patients to assess the possible formation of gallstone and nephrolithiasis.Keywords
This publication has 37 references indexed in Scilit:
- Ceftriaxone associated nephrolithiasis: a prospective study in 284 childrenPediatric Nephrology, 2007
- Ceftriaxone‐associated biliary pseudolithiasis in childrenJournal of Clinical Ultrasound, 2006
- PEDIATRIC CEFTRIAXONE NEPHROLITHIASISJournal of Urology, 2005
- Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 childrenArchives of Disease in Childhood, 2004
- Ceftriaxone‐induced biliary pseudolithiasis and urinary bladder sludgePediatrics International, 2004
- Biliary Complications in the Treatment of Unsubstantiated Lyme DiseaseThe Journal of Infectious Diseases, 1995
- Apparent biliary pseudolithiasis during ceftriaxone therapyAntimicrobial Agents and Chemotherapy, 1990
- REVERSIBLE CEFTRIAXONE-ASSOCIATED BILIARY PSEUDOLITHIASIS IN CHILDRENThe Lancet, 1988
- Ceftriaxone A Review of its Antibacterial Activity, Pharmacological Properties and Therapeutic UseDrugs, 1984
- Ceftriaxone: renal and biliary excretion and effect on the colon microfloraJournal of Antimicrobial Chemotherapy, 1982